MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:AIMN)

0.0035 +0.0002 (+6.06%)
Streaming Delayed Price Updated: 2:44 PM EDT, Jul 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about AIMN

News headline image
The Doctors Who Actually Know Things Have Spent Twenty Years Being Cited and Never Credited. Aimwell Partners Inc. Is Building the Network That Puts Their Names on the Record
From Aimwell Partners
Via ACCESS Newswire
News headline image
Aimwell Partners Inc. (OTC:AIMN) Confirms Advanced Discussions With Curated Life Sciences Capital Network
From Aimwell Partners
Via ACCESS Newswire
News headline image
Aimwell Partners Inc. (OTC: AIMN) Enters Final Negotiations to Acquire Healthcare Intellectual Property Independently Valued at $10 Million
From Aimwell Partners
Via ACCESS Newswire
News headline image
The Professionals Arrived First - Now Their Institutions are Following: Aimwell Partners Inc. Confirms Enterprise Interest Driven by Its Credentialed Observer Network
From Aimwell Partners
Via ACCESS Newswire
News headline image
Every AI Intelligence Platform Asks the Market to Trust Its Numbers. Aimwell Partners Inc. (OTC:AIMN) Just Opened the Data
From Aimwell Partners
Via ACCESS Newswire
News headline image
Aimwell Partners Inc. Publishes the Adversarial Validation Standard, v1, an Open Methodology Framework for Verifying AI-Generated Biopharma Intelligence
From Aimwell Partners
Via ACCESS Newswire
News headline image
AimwellBio Continues Onboarding Healthcare Professionals to Its Verified Observer Network, Adds One-Click LinkedIn Signup
From Aimwell Partners
Via ACCESS Newswire
News headline image
AIMN: As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor
From Aimwell Partners
Via ACCESS Newswire
News headline image
AimwellBio Expands Platform Capabilities to Strengthen the Infrastructure Behind Trusted Healthcare Intelligence
From Aimwell Partners
Via ACCESS Newswire
News headline image
AimwellBio Opens Verified Observer Network to Healthcare, Research, and Capital Professionals at No Cost
Via ACCESS Newswire
News headline image
The Question No Telehealth Underwriter Wants Asked: When was Your Platform Last Breached, and Would You Even Know?
Via ACCESS Newswire
News headline image
As Healthcare's Software Leaders Race to Add AI, AimwellBio.com Moves to Build the Layer That Verifies It
Via ACCESS Newswire
News headline image
AimwellBio Opens a Door Most People Will Not Be Allowed Through, And Healthcare's Sharpest Professionals Are Already Walking In
Via ACCESS Newswire
News headline image
Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself
Via ACCESS Newswire
News headline image
The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI
Via ACCESS Newswire
News headline image
Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians
Via ACCESS Newswire
News headline image
The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For.
Via ACCESS Newswire
News headline image
Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones
Via ACCESS Newswire
News headline image
While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t.
Via ACCESS Newswire
News headline image
AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape
Via ACCESS Newswire
News headline image
AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings
Via ACCESS Newswire
News headline image
Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure
Via ACCESS Newswire
News headline image
Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma
Via ACCESS Newswire
News headline image
AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio
Via ACCESS Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story